| N = | OR(LCI, UCI)per 5 year increase in Age | Predictor direction (p<0.05) | N = | OR(LCI, UCI)per decrease in each IRSED category (1-5) | Predictor direction (p<0.05) |
---|---|---|---|---|---|---|
Adult | ||||||
Diabetes complications | 55,007 | 1.10 (1.08, 1.12) | Older | 55,007 | 1.14 (1.08, 1.20) | Q1 (high disadvantage)) |
COPD | 13,555 | 1.20 (1.18, 1.21) | Older | 13,555 | 1.00 (0.96, 1.03) | — |
Dehydration & gastroenteritis | 12,145 | 0.88 (0.87, 0.89) | Younger | 12,145 | 0.91 (0.85, 0.97) | Q5 (low disadvantage) |
Congestive heart failure | 11,676 | 1.45 (1.41, 1.48) | Older | 11,676 | 0.95 (0.90, 1.00) | — |
Angina | 11,130 | 1.10 (1.09, 1.11) | Older | 11,130 | 1.03 (0.96, 1.10) | — |
Paediatric | ||||||
Dental Conditions | 5,705 | 1.23 (1.16, 1.31) | Older | 5,705 | 1.01 (0.92, 1.11) | — |
Asthma | 4,642 | 0.83 (0.80, 0.88) | Younger | 4,642 | 1.08 (0.92, 1.17) | — |
Ear, nose & throat infection | 4,077 | 0.62 (0.57, 0.67) | Younger | 4,077 | 0.92 (0.86, 0.98) | Q5 (low disadvantage) |
Convulsions & epilepsy | 2,125 | 0.89 (0.82, 0.98) | Younger | 2,125 | 0.97 (0.87, 1.08) | — |
Pyelonephritis | 1,150 | 0.80 (0.68, 0.93) | Younger | 1,150 | 1.06 (1.00, 1.14NN | — |